secwatch.observer — SEC 8-K summary
======================================

Issuer:     GENELUX Corp (GNLX)
CIK:        0001231457
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001493152-26-011649
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genelux enters $100M at-the-market equity offering agreement with TD Cowen
--------------------------------------------------------------------------

- Sales Agreement with TD Cowen allows offering of common stock up to $100M aggregate.
- TD Cowen receives up to 3.0% commission on gross proceeds from sales.
- Proceeds for general corporate purposes, including R&D, clinical trials, and capex.
- Company has no obligation to sell shares; may suspend at any time.
- Shares offered via at-the-market program on Nasdaq or negotiated transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1231457/000149315226011649/0001493152-26-011649-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1231457/000149315226011649/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-011649

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer